Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Effect of 25-hydroxyvitamin D and a Structured Exercise Program on Dialysis Patients

This study has been completed.
Information provided by (Responsible Party):
Neil Boudville, Sir Charles Gairdner Hospital Identifier:
First received: November 26, 2008
Last updated: June 6, 2013
Last verified: June 2013
This study aims to examine the effect of 25 hydroxyvitamin D supplementation and a structured exercise program on the exercise capacity and quality of life of haemodialysis patients with 25 hydroxyvitamin D insufficiency.

Condition Intervention Phase
End Stage Kidney Disease
Other: Structured Exercise program
Drug: Cholecalciferol (25-Hydroxyvitamin D)
Other: Usual exercise
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: The Effect of 25-hydroxyvitamin D Supplementation and a Structured Exercise Program on Exercise Capacity and Quality of Life in Dialysis Patients

Resource links provided by NLM:

Further study details as provided by Sir Charles Gairdner Hospital:

Primary Outcome Measures:
  • Exercise capacity - modified shuttle walk test [ Time Frame: Basesline, 3 & 6 months ]

Secondary Outcome Measures:
  • Quality of life with KDQOL [ Time Frame: Baseline, 3 & 6 months ]
  • Quadriceps Strength [ Time Frame: Baseline, 3 & 6 months ]
  • Serum phosphate [ Time Frame: baselibe, 3 & 6 months ]
  • Feeling thermometer [ Time Frame: Baseline, 3 & 6 months ]
  • Timed up and go [ Time Frame: baseline, 3 & 6 months ]
  • Falls [ Time Frame: continuous ]
  • Pulse wave velocity [ Time Frame: baseline, 3 & 6 months ]
  • Bioimpedance [ Time Frame: Baseline, 3 & 6 months ]

Enrollment: 19
Study Start Date: January 2009
Study Completion Date: September 2011
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Structured exercise program
Participants will be randomised at 3 months into either this group or the comparator of usual exercise.
Other: Structured Exercise program
30 minutes on an exercise bicycle during every dialysis
Experimental: Vitamin D
Cholecalciferol 2000U per day will be given to all participants for the duration of the study
Drug: Cholecalciferol (25-Hydroxyvitamin D)
Cholecalciferol 2000U per day will be given for duration of study to all participants
Placebo Comparator: Usual exercise
Participants randomised to this arm, at 3 months, will continue on their usual exercise routine
Other: Usual exercise
Participants randomised to this arm at 3 months will continue on their usual exercise routine for the remaining 3 months


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Stable on dialysis for at least 3 months
  2. Able to obtain informed consent
  3. Medically stable
  4. Dialysis adequacy at target for small solute clearance (ie Kt/V>1.2 or Urea reduction ratio>65%)
  5. Serum 25-hydroxyvitamin D levels less than 75nmol/L at baseline

Exclusion Criteria:

  1. Limb Amputation
  2. Impaired cognition
  3. Impaired vision
  4. Haemoglobin concentration < 110g/L
  5. Change in Erythropoiesis stimulating agent dose over the last 2 months
  6. Unable or unwilling to comply with exercise program
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00798993

Australia, Western Australia
Sir Charles Gairdner Hospital
Perth, Western Australia, Australia, 6009
Sponsors and Collaborators
Sir Charles Gairdner Hospital
Principal Investigator: Ben Bull Sir Charles Gairdner Hospital
Study Director: Neil Boudville Sir Charles Gairdner Hospital
  More Information

Responsible Party: Neil Boudville, Associate Professor, Sir Charles Gairdner Hospital Identifier: NCT00798993     History of Changes
Other Study ID Numbers: SCGH25OHD2008
Study First Received: November 26, 2008
Last Updated: June 6, 2013

Keywords provided by Sir Charles Gairdner Hospital:
Chronic kidney failure
25 hydroxyvitamin D
quadriceps strength

Additional relevant MeSH terms:
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency, Chronic
Urologic Diseases
Renal Insufficiency
Vitamin D
Growth Substances
Physiological Effects of Drugs
Bone Density Conservation Agents processed this record on May 25, 2017